Table 4.
BACS | ||||||||
---|---|---|---|---|---|---|---|---|
VL | WM | MoF | VF | AP | EF | COM | ||
SWNS | TS | −.03 | −.05 | .03 | −.24 | .29 | .17 | .08 |
MeF | −.07 | .13 | .05 | −.19 | .24 | .33 | .21 | |
SC | −.28 | .01 | .02 | −.27 | .06 | .16 | −.08 | |
ER | .11 | −.15 | .23 | .09 | .46* | −.03 | .20 | |
PF | −.13 | .03 | .14 | −.20 | .09 | .26 | .14 | |
SI | .08 | −.05 | .03 | -.13 | .23 | .33 | .24 |
BACS brief assessment of cognition in schizophrenia, SWNS subjective well-being under neuroleptic drug treatment short form, VL verbal learning, WM working memory, MF motor function, VF verbal fluency, AP attention and processing speed, EF executive function, COM composite score, TS total score, MF mental function, SC self-control, ER emotional regulation, PF physical functioning, SI social integration
*p < .05